PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18814144-0	2008	Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.	Cholecalciferol	55-65	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	20-25	
35196318-4	2022	The current study investigated the effect of TGF-beta1 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in stromal cells induced by 1alpha,25(OH)2D3 (D3) and dexamethasone (Dex).	Cholecalciferol	175-177	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	58-109	
35196318-4	2022	The current study investigated the effect of TGF-beta1 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in stromal cells induced by 1alpha,25(OH)2D3 (D3) and dexamethasone (Dex).	Cholecalciferol	175-177	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	111-116	
35196318-5	2022	TGF-beta1 downregulated the expression of RANKL induced by D3 and Dex in mouse bone marrow stromal lineage, ST2 cells.	Cholecalciferol	59-61	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	42-47	
35196318-11	2022	These results indicated that TGF-beta1 downregulates RANKL expression and the osteoclast-supporting activity of osteoblasts/stromal cells induced by D3 and Dex through the degradation of the RXR-alpha protein mediated by ubiquitin-proteasome system.	Cholecalciferol	149-151	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	53-58	
25716813-3	2015	Meanwhile, the active form of vitamin D3, 1alpha, 25-dihydroxyvitamin D3 [1alpha, 25 (OH) 2D3], upregulates expression of receptor activator of nuclear factor-kappaB ligand (RANKL) in osteoblastic cells.	Cholecalciferol	30-40	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	122-172	
25716813-3	2015	Meanwhile, the active form of vitamin D3, 1alpha, 25-dihydroxyvitamin D3 [1alpha, 25 (OH) 2D3], upregulates expression of receptor activator of nuclear factor-kappaB ligand (RANKL) in osteoblastic cells.	Cholecalciferol	30-40	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	174-179	
25716813-8	2015	However, daily administration of an active vitamin D3 analog (eldecalcitol, an osteoporotic therapeutic drug) for a month suppressed RANKL expression in osteoblasts, resulting in suppression of bone resorption.	Cholecalciferol	43-53	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	133-138	
23220095-4	2013	The active form of vitamin D3, 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3], is known to be a hormone which enhances RANKL expression in vitro.	Cholecalciferol	19-29	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	121-126	
18489902-0	2008	Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.	Cholecalciferol	6-16	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	112-117	
26399683-6	2015	Bropirimine partially suppressed the expression of RANKL mRNA in UAMS-32 cells induced by activated vitamin D3.	Cholecalciferol	100-110	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	51-56